Indications and uses
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: sneezing runny nose itchy, watery eyes itching of the nose or throat
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: sneezing runny nose itchy, watery eyes itching of the nose or throat
take only as directed always use the provided measurement spoon. A full spoon equals 3mL. adults and children 12 years of age and over: oral dosage is 3 mL every 4 to 6 hours, not to exceed 18 mL in 24 hours, or as directed by a doctor. children under 12 years of age: consult a doctor.
store in refrigerator after opening at between 35 and 41 degrees F (2-5 degrees C)
Each 3 mL dose contains Doxylamine succinate 9.78 mg
Doxylamine succinate 9.78 mg.........Antihistamine
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
Ask a doctor before use if you have
Ask a doctor or pharmacist before useif you are taking sedatives or tranquilizers.
When using this product
If pregnant or breast feeding,ask a health professional before use
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Citric Acid, Glycerin, Herbal alcohol-water extract from 7 organic herbs(California Poppy, Hawthorn, Hops, Mistletoe, Oat, Passion flower, White chestnut) Honey, Potassium Sorbate, Sugar, Tragacanth, Vanilla, and Water.
store in refrigerator after opening at between 35 and 41 degrees F (2-5 degrees C)
Directions - 8/2024
sambrosa
sweet dreams
Night Syrup
For allergy relief to have a good night's rest
With Doxylamine (antihistamine) 9.78 mg
In a great-tasting base of honey and 7 organic herbs.
300mL
10.14 fl oz
Alcohol 3% vol.
| Class | Version | Type | Effective |
|---|---|---|---|
| DOXYLAMINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 59361619-24d9-b610-eca6-5a7f25ed5e03 | Product name | 5 | 20240909 |
| f4368033-af8c-41bf-a84b-ff77392b8522 | Product name | 1 | 20161229 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 80148-001-01 | 2025-07-29 | C162847 | 48780-1 | 3b156c62-2cd0-fb37-e063-e6dba90a4e07 | adca020a-29e7-ecdd-e053-2a95a90a0b94 |
| 80148-001-02 | 2025-07-29 | C162847 | 48780-1 | 3b156c62-2cd0-fb37-e063-e6dba90a4e07 | adca020a-29e7-ecdd-e053-2a95a90a0b94 |
| 80148-001-03 | 2025-07-29 | C162847 | 48780-1 | 3b156c62-2cd0-fb37-e063-e6dba90a4e07 | adca020a-29e7-ecdd-e053-2a95a90a0b94 |
| 80148-001-04 | 2025-07-29 | C162847 | 48780-1 | 3b156c62-2cd0-fb37-e063-e6dba90a4e07 | adca020a-29e7-ecdd-e053-2a95a90a0b94 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80148-001-01 | Sambrosanight | 100 mL in 1 BOTTLE | SYRUP | 100 | 7 | |
| 80148-001-01 | Sambrosanight | 1 in 1 CARTON | SYRUP | 1 | 7 | |
| 80148-001-02 | Sambrosanight | 1 in 1 CARTON | SYRUP | 1 | 7 | |
| 80148-001-02 | Sambrosanight | 30 mL in 1 BOTTLE | SYRUP | 30 | 7 | |
| 80148-001-03 | Sambrosanight | 300 mL in 1 BOTTLE | SYRUP | 300 | 7 | |
| 80148-001-03 | Sambrosanight | 1 in 1 CARTON | SYRUP | 1 | 7 | |
| 80148-001-04 | Sambrosanight | 3 mL in 1 POUCH | SYRUP | 3 | 7 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 80148-001 | 80148-001-01, 80148-001-03, 80148-001-02, 80148-001-04 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2553124a-3ebf-365d-e063-6294a90a4224 | adca020a-29e7-ecdd-e053-2a95a90a0b94 | 2024-08-07 | Warnings | 2553124a-3ebf-365d-e063-6294a90a4224 adca020a-29e7-ecdd-e053-2a95a90a0b94 |
Adverse event summaries are temporarily unavailable. Other product information remains available.